Bio­gen, Ei­sai un­veil new da­ta on lecanemab, but ques­tions linger on ARIA-E; Spa­tial bi­ol­o­gy out­fit grabs $33M round

Ei­sai and Bio­gen have re­leased more da­ta on lecanemab, an­oth­er an­ti-Alzheimer’s drug in the part­ner­ship that spawned ad­u­canum­ab. How­ev­er, ques­tions about the da­ta re­main when …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER